Huawei Chen
Impact in
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Genomics and Phylogenetic Studies
- Cancer-related gene regulation
- DNA Repair Mechanisms
- Chemical Synthesis and Analysis
Papers in
-
- Vector-borne infectious diseases 5
- Pharmacology 13
- Microbial Natural Products and Biosynthesis 12
- Co-authors
- Christopher T. WalshBrian K. HubbardSarah E. O’ConnorSteven X. HouHeather C. LoseyJiaquan WuWei‐Mei ChingMaría Julia Marinissen
- Journals
- Biochemistry (4 papers)Proceedings of the National Academy of Sciences (4 papers)Cancer Research (4 papers)ACS Chemical Biology (3 papers)Journal of the American Chemical Society (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Huawei Chen
75 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 112
- Pharmacology 810
- Molecular Biology 2.1k
- Biotechnology 252
- Oncology 394
- Cell Biology 226
Countries citing papers authored by Huawei Chen
This map shows the geographic impact of Huawei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huawei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huawei Chen more than expected).
Fields of papers citing papers by Huawei Chen
This network shows the impact of papers produced by Huawei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huawei Chen. The network helps show where Huawei Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huawei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 1 | |
| 9 | 2018 | 67 | |
| 10 | 2018 | 205 | |
| 11 | 2017 | 16 | |
| 12 | 2016 | 7 | |
| 13 | A Clinical Research on Treatment of Infant Recurrent Respiratory Infection with Combination of Traditional Chinese Medicine and Western Medicine | 2013 | 1 |
| 14 | 2012 | 85 | |
| 15 | 2012 | 118 | |
| 16 | 2007 | 41 | |
| 17 | 2003 | 37 | |
| 18 | 2001 | 83 | |
| 19 | 2001 | 142 | |
| 20 | 1997 | 33 |
About Huawei Chen
Huawei Chen is a scholar working on Parasitology, Pharmacology, Molecular Biology, Molecular Medicine and Biotechnology, having authored 81 papers that have together received 2.9k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (12 papers), Mosquito-borne diseases and control (7 papers), Epigenetics and DNA Methylation (7 papers), Biosensors and Analytical Detection (6 papers), Cancer-related gene regulation (6 papers), Protein Degradation and Inhibitors (6 papers), Cancer Mechanisms and Therapy (5 papers) and Vector-borne infectious diseases (5 papers). The work is most often cited by research in Pharmacology (810 citations), Molecular Biology (2.1k citations), Biotechnology (252 citations), Oncology (394 citations) and Cell Biology (226 citations). Huawei Chen has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Christopher T. Walsh, Brian K. Hubbard, Christopher T. Walsh, Sarah E. O’Connor, Steven X. Hou, Heather C. Losey, Jiaquan Wu, Wei‐Mei Ching, María Julia Marinissen and J. Silvio Gutkind. Their work appears in journals such as Biochemistry, Proceedings of the National Academy of Sciences, Cancer Research, ACS Chemical Biology and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.